Pfizer (PFE) Receives a Hold from Credit Suisse
May 16 2022 - 09:15PM
TipRanks
Credit Suisse analyst Lorenzo Biasio maintained a Hold rating on
Pfizer (PFE – Research Report) yesterday and set a price target of
$54.00. The company's shares closed last Monday at $50.67.
According to TipRanks.com, Biasio is a 4-star analyst with an
average return of 7.1% and a 61.3% success rate. Biasio covers the
Healthcare sector, focusing on stocks such as Coherus Biosciences,
Intuitive Surgical, and Boston Scientific. Pfizer has an analyst
consensus of Moderate Buy, with a price target consensus of $58.92,
which is a 18.1% upside from current levels. In a report issued on
May 3, Mizuho Securities also maintained a Hold rating on the stock
with a $55.
https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-credit-suisse?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
Historical Stock Chart
From Jul 2022 to Aug 2022
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2021 to Aug 2022